163 related articles for article (PubMed ID: 34350376)
1. Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance Market.
Shih YT; Xu Y; Zhao H; Schrag D; Yao J
JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34350376
[TBL] [Abstract][Full Text] [Related]
2. Patient out-of-pocket payments for oral oncolytics: results from a 2009 US claims data analysis.
Raborn ML; Pelletier EM; Smith DB; Reyes CM
Am J Manag Care; 2012 May; 18(5 Spec No. 2):SP57-64. PubMed ID: 22693982
[TBL] [Abstract][Full Text] [Related]
3. Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans.
Leopold C; Wagner AK; Zhang F; Lu CY; Earle CC; Nekhlyudov L; Ross-Degnan D; Wharam JF
Breast Cancer Res Treat; 2018 Sep; 171(2):449-459. PubMed ID: 29855813
[TBL] [Abstract][Full Text] [Related]
4. How Have Patient Out-of-pocket Costs for Common Outpatient Orthopaedic Foot and Ankle Surgical Procedures Changed Over Time? A Retrospective Study From 2010 to 2020.
Goldfarb SI; Xu AL; Gupta A; Mun F; Durand WM; Gonzalez TA; Aiyer AA
Clin Orthop Relat Res; 2024 Feb; 482(2):313-322. PubMed ID: 37498201
[TBL] [Abstract][Full Text] [Related]
5. Out-of-Pocket Spending for Non-Birth-Related Hospitalizations of Privately Insured US Children, 2017 to 2019.
Carlton EF; Becker NV; Moniz MH; Scott JW; Prescott HC; Chua KP
JAMA Pediatr; 2023 May; 177(5):516-525. PubMed ID: 36972040
[TBL] [Abstract][Full Text] [Related]
6. Impact of Patient Reimbursement Timing and Patient Out-of-Pocket Expenses on Medication Adherence in Patients Covered by Private Drug Insurance Plans.
Després F; Forget A; Kettani FZ; Blais L
J Manag Care Spec Pharm; 2016 May; 22(5):539-47. PubMed ID: 27123915
[TBL] [Abstract][Full Text] [Related]
7. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
McGarvey N; Gitlin M; Fadli E; Chung KC
J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
[TBL] [Abstract][Full Text] [Related]
8. Patient Out-of-Pocket Cost Burden With Elective Orthopaedic Surgery.
Durand WM; Ortiz-Babilonia CD; Badin D; Wang KY; Jain A
J Am Acad Orthop Surg; 2022 Jul; 30(14):669-675. PubMed ID: 35797680
[TBL] [Abstract][Full Text] [Related]
9. Comparing Health Care Financial Burden With an Alternative Measure of Unaffordability.
Kielb ES; Rhyan CN; Lee JA
Inquiry; 2017 Jan; 54():46958017732960. PubMed ID: 28975850
[TBL] [Abstract][Full Text] [Related]
10. Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer.
Lu CY; Zhang F; Wagner AK; Nekhlyudov L; Earle CC; Callahan M; LeCates R; Xu X; Ross-Degnan D; Wharam JF
Breast Cancer Res Treat; 2018 Aug; 171(1):235-242. PubMed ID: 29754304
[TBL] [Abstract][Full Text] [Related]
11. Financial Burden of Traumatic Injury Amongst the Privately Insured.
Fu SJ; Arnow K; Trickey A; Spain DA; Morris A; Knowlton L
Ann Surg; 2022 Mar; 275(3):424-432. PubMed ID: 34596072
[TBL] [Abstract][Full Text] [Related]
12. Understanding out-of-pocket spending and financial hardship among patients who succumb to cancer and their caregivers.
Tur-Sinai A; Urban D; Azoulay D; Bar-Sela G; Bentur N
Isr J Health Policy Res; 2022 Jan; 11(1):1. PubMed ID: 34980264
[TBL] [Abstract][Full Text] [Related]
13. Managing Urban Stroke Health Expenditures in China: Role of Payment Method and Hospital Level.
Yang Y; Man X; Yu Z; Nicholas S; Maitland E; Huang Z; Ma Y; Shi X
Int J Health Policy Manag; 2022 Dec; 11(11):2698-2706. PubMed ID: 35219287
[TBL] [Abstract][Full Text] [Related]
14. Financial burden of healthcare for cancer patients with social medical insurance: a multi-centered study in urban China.
Mao W; Tang S; Zhu Y; Xie Z; Chen W
Int J Equity Health; 2017 Oct; 16(1):180. PubMed ID: 29017542
[TBL] [Abstract][Full Text] [Related]
15. Total and out-of-pocket costs of different primary management strategies in ovarian cancer.
Suidan RS; He W; Sun CC; Zhao H; Rauh-Hain JA; Fleming ND; Lu KH; Giordano SH; Meyer LA
Am J Obstet Gynecol; 2019 Aug; 221(2):136.e1-136.e9. PubMed ID: 30965052
[TBL] [Abstract][Full Text] [Related]
16. Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price Trends.
Atzinger CB; Guo JJ
Am Health Drug Benefits; 2017 Feb; 10(1):27-36. PubMed ID: 28465766
[TBL] [Abstract][Full Text] [Related]
17. Financial Hardship After Traumatic Injury: Risk Factors and Drivers of Out-of-Pocket Health Expenses.
O'Neill KM; Jean RA; Gross CP; Becher RD; Khera R; Elizondo JV; Nasir K
J Surg Res; 2020 Dec; 256():1-12. PubMed ID: 32663705
[TBL] [Abstract][Full Text] [Related]
18. Financial Impact of Out-of-Pocket Costs Among Patients Undergoing Resection for Colorectal Carcinoma.
Paro A; Hyer JM; Shaikh CF; Pawlik TM
Ann Surg Oncol; 2022 Sep; 29(9):5387-5397. PubMed ID: 35430665
[TBL] [Abstract][Full Text] [Related]
19. The Increasing Financial Burden of Outpatient Elective Surgery for the Privately Insured.
Billig JI; Lan WC; Chung KC; Kuo CF; Sears ED
Ann Surg; 2020 Sep; 272(3):530-536. PubMed ID: 32740255
[TBL] [Abstract][Full Text] [Related]
20. Out-of-Pocket Costs Among Patients With a New Cancer Diagnosis Enrolled in High-Deductible Health Plans vs Traditional Insurance.
Fu SJ; Rose L; Dawes AJ; Knowlton LM; Ruddy KJ; Morris AM
JAMA Netw Open; 2021 Dec; 4(12):e2134282. PubMed ID: 34935922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
